Severe Gastritis Due to Nivolumab Treatment of a Metastatic Melanoma Patient.

Samonis, George; Bousmpoukea, Aikaterini; Molfeta, Aristea; Kalkinis, Antonios D; Petraki, Kalliopi; Koutserimpas, Christos; Bafaloukos, Dimitrios

Samonis, George; Bousmpoukea, Aikaterini; Molfeta, Aristea; Kalkinis, Antonios D; Petraki, Kalliopi; Koutserimpas, Christos; Bafaloukos, Dimitrios.

Afiliação

Samonis G; First Oncology Department, Metropolitan Hospital, Neon Faliron, 18547 Athens, Greece.
Bousmpoukea A; First Oncology Department, Metropolitan Hospital, Neon Faliron, 18547 Athens, Greece.
Molfeta A; First Oncology Department, Metropolitan Hospital, Neon Faliron, 18547 Athens, Greece.
Kalkinis AD; Department of Nuclear Medicine, Metropolitan Hospital, Neon Faliron, 18547 Athens, Greece.
Petraki K; Department of Pathology, Metropolitan Hospital, Neon Faliron, 18547 Athens, Greece.
Koutserimpas C; Department of Orthopaedics and Traumatology, "251" Hellenic Air Force General Hospital of Athens, 11525 Athens, Greece.
Bafaloukos D; First Oncology Department, Metropolitan Hospital, Neon Faliron, 18547 Athens, Greece.

Diagnostics (Basel) ; 12(11)2022 Nov 18.

Article em En | MEDLINE | ID: mdl-36428923

Palavras-chave

corticosteroids; gastritis; melanoma; nivolumab

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Diagnostics (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Grécia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google